Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Mauri

Showing results (251-260 of 335) with videos related to

Pageof 34
Sort By:
JACC. Cardiovascular Interventions|January 25, 2016
Temporal Trends and Outcomes of Patients Undergoing Percutaneous Coronary Interventions for Cardiogenic Shock in the Setting of Acute Myocardial Infarction: A Report From the CathPCI RegistrySiddharth A Wayangankar, Sripal Bangalore, Lisa A McCoy, et al.
Circulation. Cardiovascular Quality and Outcomes|November 18, 2014
Evaluating the generalizability of a large streamlined cardiovascular trial: comparing hospitals and patients in the dual antiplatelet therapy study versus the National Cardiovascular Data RegistryRobert W Yeh, Matthew J Czarny, Sharon-Lise T Normand, et al.
The American Journal of Cardiology|November 9, 2002
Cutting balloon angioplasty for the prevention of restenosis: results of the Cutting Balloon Global Randomized TrialLaura Mauri, Raoul Bonan, Bonnie H Weiner, et al.
JACC. Cardiovascular Interventions|May 26, 2009
A prospective feasibility trial investigating the use of the Impella 2.5 system in patients undergoing high-risk percutaneous coronary intervention (The PROTECT I Trial): initial U.S. experienceSimon R Dixon, José P S Henriques, Laura Mauri, et al.
Journal of Thrombosis and Thrombolysis|July 20, 2020
Biomarkers of platelet activation and cardiovascular risk in the DAPT trialDavid D Berg, Robert W Yeh, Laura Mauri, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|May 11, 2018
A lysosome-plasma membrane-sphingolipid axis linking lysosomal storage to cell growth arrestMaura Samarani, Nicoletta Loberto, Giulia Soldà, et al.
The American Journal of Cardiology|June 7, 2017
Usefulness of Intracoronary Brachytherapy for Patients With Resistant Drug-Eluting Stent RestenosisFernanda M Mangione, Tannas Jatene, Roza Badr Eslam, et al.
Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids|June 17, 2023
GM1 oligosaccharide efficacy against α-synuclein aggregation and toxicity in vitroMaria Fazzari, Erika Di Biase, Ludovica Zaccagnini, et al.
Circulation. Cardiovascular Interventions|March 10, 2016
Temporal Trends in the Risk Profile of Patients Undergoing Outpatient Percutaneous Coronary Intervention: A Report from the National Cardiovascular Data Registry's CathPCI RegistryAmit N Vora, Dadi Dai, Hitinder Gurm, et al.
European Heart Journal|September 2, 2015
Long-term dual antiplatelet therapy for secondary prevention of cardiovascular events in the subgroup of patients with previous myocardial infarction: a collaborative meta-analysis of randomized trialsJacob A Udell, Marc P Bonaca, Jean-Philippe Collet, et al.
Pageof 34

Showing results (251-260 of 335) with videos related to

Sort By:
Pageof 34
JACC. Cardiovascular Interventions|January 25, 2016
Temporal Trends and Outcomes of Patients Undergoing Percutaneous Coronary Interventions for Cardiogenic Shock in the Setting of Acute Myocardial Infarction: A Report From the CathPCI RegistrySiddharth A Wayangankar, Sripal Bangalore, Lisa A McCoy, et al.
Circulation. Cardiovascular Quality and Outcomes|November 18, 2014
Evaluating the generalizability of a large streamlined cardiovascular trial: comparing hospitals and patients in the dual antiplatelet therapy study versus the National Cardiovascular Data RegistryRobert W Yeh, Matthew J Czarny, Sharon-Lise T Normand, et al.
The American Journal of Cardiology|November 9, 2002
Cutting balloon angioplasty for the prevention of restenosis: results of the Cutting Balloon Global Randomized TrialLaura Mauri, Raoul Bonan, Bonnie H Weiner, et al.
JACC. Cardiovascular Interventions|May 26, 2009
A prospective feasibility trial investigating the use of the Impella 2.5 system in patients undergoing high-risk percutaneous coronary intervention (The PROTECT I Trial): initial U.S. experienceSimon R Dixon, José P S Henriques, Laura Mauri, et al.
Journal of Thrombosis and Thrombolysis|July 20, 2020
Biomarkers of platelet activation and cardiovascular risk in the DAPT trialDavid D Berg, Robert W Yeh, Laura Mauri, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|May 11, 2018
A lysosome-plasma membrane-sphingolipid axis linking lysosomal storage to cell growth arrestMaura Samarani, Nicoletta Loberto, Giulia Soldà, et al.
The American Journal of Cardiology|June 7, 2017
Usefulness of Intracoronary Brachytherapy for Patients With Resistant Drug-Eluting Stent RestenosisFernanda M Mangione, Tannas Jatene, Roza Badr Eslam, et al.
Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids|June 17, 2023
GM1 oligosaccharide efficacy against α-synuclein aggregation and toxicity in vitroMaria Fazzari, Erika Di Biase, Ludovica Zaccagnini, et al.
Circulation. Cardiovascular Interventions|March 10, 2016
Temporal Trends in the Risk Profile of Patients Undergoing Outpatient Percutaneous Coronary Intervention: A Report from the National Cardiovascular Data Registry's CathPCI RegistryAmit N Vora, Dadi Dai, Hitinder Gurm, et al.
European Heart Journal|September 2, 2015
Long-term dual antiplatelet therapy for secondary prevention of cardiovascular events in the subgroup of patients with previous myocardial infarction: a collaborative meta-analysis of randomized trialsJacob A Udell, Marc P Bonaca, Jean-Philippe Collet, et al.
Pageof 34